Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
05-Aug-2026 | Source : BSESchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
05-Aug-2026 | Source : BSESchedule of Conference Call to discuss financial performance for quarter ended June 30 2026
Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday August 10 2026
04-Aug-2026 | Source : BSEWindlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.
Corporate Actions
No Upcoming Board Meetings
Windlas Biotech Ltd has declared 126% dividend, ex-date: 16 Jul 26
No Splits history available
No Bonus history available
No Rights history available